HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dentek Consumption Dip Slows Prestige Sales Despite Digestion, Eye Care Gains

Executive Summary

Prestige Consumer Healthcare sales in North America in its latest quarter fell 3.9% as retailers slowed on orders of Dentek oral care products. Compound W and Nix lice treatment brands have ‘runway’ for long-term growth on line extensions and marketing.

You may also be interested in...



Dentek Destocking Takes Bite Off Prestige Topline Despite Brand-Building

Dentek oral care brand struggles with retailer destocking as Prestige Consumer Healthcare continues brand-building including working with retailers to expand inventory and running TV campaigns on nighttime teeth grinding. Firm reports net sells fell 8.6% in its latest quarter.

Prestige Routes Summer’s Eve, Dentek ‘Brand Building’ On Dramamine Path

Prestige Consumer Healthcare is launching two products under Summer’s Eve brand for feminine hygiene during menstruation and professional-grade mouth guard under Dentek, as well as other products that will help grow "leading but under-invested” brands.

DenTek Deal Expands Prestige Brands’ Oral Care Portfolio, OTC Focus

While overall oral care sales grow 2.4% in the 52-week period through Oct. 3, sales of the sub-category of floss picks, dental guards, interdental brushes, disposable picks, dental wax, floss threaders, dental picks and tongue cleaners grew 9%. DenTek is first in floss pick sales and second in interdental brush sales.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel